We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Nova Tech Enterprises Inc (PK) | USOTC:NTEI | OTCMarkets | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.71 | 0.70 | 1.18 | 0.00 | 14:30:22 |
From May 2019 to May 2024
LAS VEGAS, March 11, 2014 /PRNewswire/ -- In keeping with CleanPath Resources pursuit of cutting edge nutraceuticals, we have some exciting preliminary test results. Recently, in vitro laboratory experiments using CleanPath Resources, Corp.'s Nutraload™ stem cell product has shown an inhibitory affect on the growth of multiple cancer cell lines including the A549, HY-29, PC-3, and SGC-7901 cancer cell lines. Additional testing will be done, as we did previously in showing a 268% increase in adult stem cells from a previous announcement using this Nutraload product. These exciting results are forming the foundation of the firm's objective to create innovative products to address wellness issues with natural ingredients. You can learn more at our website www.re-load.biz.
CleanPath Resources, Corp. (CLNP)
2400 S Cimarron Rd. Suite 120B
Las Vegas, NV 89117
Ken Lewis
President
Tel: (561)-309-9876
Email: kenlewis@re-load.biz
SOURCE CleanPath Resources, Corp.
Copyright 2014 PR Newswire
1 Year Nova Tech Enterprises (PK) Chart |
1 Month Nova Tech Enterprises (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
